CClinicalTrials.gg
CompletedNCT03304652Updated Mar 14, 2019

Cerebral MRI During Sleep

An observational study in Sleep, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2019-03-14.

Sponsored by University of California, San Diego · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
11
Ages
18 Years to 59 Years
Sex
All
01

Study summary

Recent studies in animal models have suggested a critical role for cerebrospinal fluid and Interstitial fluid flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. This effect is modulated during sleep, suggesting a potentially important mechanism for sleep to maintain both acute homeostasis and long-term cerebral health.

The central goal of these studies is to develop a sensitive MRI biomarker of cerebral conformational changes during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation.

Read the detailed description

Recent studies in animal models have suggested a critical role for cerebrospinal fluid (CSF) / Interstitial fluid (ISF) flux through cerebral parenchyma for removal of byproducts of cellular metabolism and hence in maintaining the health of the brain. It remains unknown to what extent these phenomena exist in the human brain. A key challenge in this work is to make non-invasive and reproducible measurements of the cerebral microenvironment in humans. For these studies, the investigators have implemented a suite of MRI measurements to track physiological changes in the brain during sleep. This exploratory work aims to establish the sensitivity and reproducibility of MRI as a non-invasive neuroimaging assessment of cerebral changes during natural sleep and sedation. The long term goal of this work is to use MRI as an imaging biomarker to assess the cerebral response to normal versus disordered sleep in patients.

Our specific aims will address the following questions:

Aim 1: How sensitive are MRI metrics for determining changes in the brain during sleep?

Aim 2: How reproducible are MRI metrics during sleep and during sedation?

The investigators will recruit 12 normal adult subjects for this study (consecutive respondees to recruitment adverts). The investigators will make regional MRI measurements during onset, maintenance and waking from stage N2 sleep. From these the investigators will characterize which MRI metrics are most sensitive to changes in the cerebral environment, and how these vary for different cerebral regions.

Measurements will be repeated during \~90 minutes of natural sleep, and following oral sedation with 10 mg zaleplon (Sonata).

02

Conditions studied

  • Sleep
03

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

12 normal adults for this study aged 18-59. Both male and female. Consecutive participant sampling

Inclusion criteria

  • Healthy Adults

Exclusion criteria

Exclusion Criteria:

  1. age not in range 18-59
  2. smoking / recreational drug use
  3. pregnant women / breast feeding
  4. contraindication to MRI
  5. contraindications to Zaleplon
  6. history of cardiovascular pulmonary or cerebral disease (hypertension (diastolic >90 mmHg, systolic > 150 mmHg), unstable cerebrovascular syndromes, prior history of cardiac arrhythmias, unstable angina, chronic obstructive pulmonary disease).
  7. Current SSRI antidepressant medication
  8. History of sleep disorder or currently taking sedative / stimulant medication
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
11 participants (actual)
Patient registry
No

Interventions

  • DrugZaleplon

    Sleep Aid; 10mg; Oral; Single Use

    Also known as: Sonata

  • OtherNatural Sleep

    Natural Sleep without medication

05

What researchers measure

Primary outcomes

  1. Cerebral MRI Changes

    Change in MRI Signal from Awake Baseline

    Time frame: 90 Minutes of Sleep

06

Study locations

1 site
  • UC San Diego
    San Diego, California 92093-0677, United States
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03304652
Lead sponsor
University of California, San Diego
Responsible party
David Dubowitz (Associate Professor, University of California, San Diego) — Principal investigator
First posted
Oct 9, 2017
Start date
Oct 1, 2017
Primary completion
Oct 31, 2018
Completion
Oct 31, 2018
Last update
Mar 14, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion